Shopping Cart
Remove All
Your shopping cart is currently empty
Catumaxomab (LP-000) is a rat-mouse hybrid lgG2 monoclonal and bispecific antibody that binds to the antigens CD3 and EpCAM (Epithelial Cell Adhesion Molecule) for the treatment of malignant ascites in cancer patients.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $328 | - | In Stock | |
| 5 mg | $859 | - | In Stock | |
| 10 mg | $1,380 | - | In Stock | |
| 25 mg | $1,980 | - | In Stock |
| Description | Catumaxomab (LP-000) is a rat-mouse hybrid lgG2 monoclonal and bispecific antibody that binds to the antigens CD3 and EpCAM (Epithelial Cell Adhesion Molecule) for the treatment of malignant ascites in cancer patients. |
| In vitro | Catumaxomab inhibits the growth of FaDu tumor spheroids co-cultured with PBMCs in a dose-dependent manner when treated at concentrations ranging from 0 to 5 ng/mL for 3 to 7 days [1]. |
| In vivo | Catumaxomab was administered intraperitoneally to patients with EpCAM-positive cancers and malignant ascites on days 0, 3, 7, and 10 at escalating doses of 10, 20, 50, and 150 μg, respectively. The treatment significantly prolonged puncture-free survival, reduced the number of EpCAM-positive tumor cells and VEGF levels in ascitic fluid, and enhanced the activation of CD4⁺ and CD8⁺ T cells [2]. |
| Synonyms | LP-000, LP000 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 509077-98-9 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.